Abstract P3-12-03: Impact of genetic polymorphisms on plasma levels of tamoxifen and its metabolites and toxicity: 6-months results of the adjuvant breast cancer longitudinal PHACS study (NCT01127295)
White-Koning, M, Arellano, C, Le Morvan, V, Evrard, A, Puzskiel, A, Vachoux, C, Dauba, J, Houyau, P, Poublanc, M, Robert, J, Boyer, J-C, Roché, H, Thomas, F, Chatelut, E
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article